These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29680234)

  • 21. Designing Formulation Strategies for Enhanced Stability of Therapeutic Peptides in Aqueous Solutions: A Review.
    Nugrahadi PP; Hinrichs WLJ; Frijlink HW; Schöneich C; Avanti C
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Viscosity of concentrated therapeutic protein compositions.
    Jezek J; Rides M; Derham B; Moore J; Cerasoli E; Simler R; Perez-Ramirez B
    Adv Drug Deliv Rev; 2011 Oct; 63(13):1107-17. PubMed ID: 22014592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceutical Perspective on Opalescence and Liquid-Liquid Phase Separation in Protein Solutions.
    Raut AS; Kalonia DS
    Mol Pharm; 2016 May; 13(5):1431-44. PubMed ID: 27017836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced protein formulations.
    Wang W
    Protein Sci; 2015 Jul; 24(7):1031-9. PubMed ID: 25858529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gauging colloidal and thermal stability in human IgG1-sugar solutions through diffusivity measurements.
    Rubin J; Sharma A; Linden L; Bommarius AS; Behrens SH
    J Phys Chem B; 2014 Mar; 118(11):2803-9. PubMed ID: 24555903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the effect of syringe surfaces on protein formulations.
    Majumdar S; Ford BM; Mar KD; Sullivan VJ; Ulrich RG; D'souza AJ
    J Pharm Sci; 2011 Jul; 100(7):2563-73. PubMed ID: 21319164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of protein and peptide stability and solubility in non-aqueous solvents.
    Stevenson CL
    Curr Pharm Biotechnol; 2000 Sep; 1(2):165-82. PubMed ID: 11467335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative evaluation of colloidal stability of antibody solutions using PEG-induced liquid-liquid phase separation.
    Wang Y; Latypov RF; Lomakin A; Meyer JA; Kerwin BA; Vunnum S; Benedek GB
    Mol Pharm; 2014 May; 11(5):1391-402. PubMed ID: 24679215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of colloidal stability of high concentration protein formulations.
    Garidel P; Blume A; Wagner M
    Pharm Dev Technol; 2015 May; 20(3):367-74. PubMed ID: 24392929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotational Rheology of Bovine Serum Albumin Solutions: Confounding Effects of Impurities, Mechanistic Considerations and Potential Implications on Protein Formulation Development.
    Gu JH; Qian R; Chou R; Bondarenko PV; Goldenberg M
    Pharm Res; 2018 Jun; 35(8):157. PubMed ID: 29904795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization and stability study of polysorbate 20 in therapeutic monoclonal antibody formulation by multidimensional ultrahigh-performance liquid chromatography-charged aerosol detection-mass spectrometry.
    Li Y; Hewitt D; Lentz YK; Ji JA; Zhang TY; Zhang K
    Anal Chem; 2014 May; 86(10):5150-7. PubMed ID: 24749737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid-State Hydrogen-Deuterium Exchange Mass Spectrometry: Correlation of Deuterium Uptake and Long-Term Stability of Lyophilized Monoclonal Antibody Formulations.
    Moorthy BS; Zarraga IE; Kumar L; Walters BT; Goldbach P; Topp EM; Allmendinger A
    Mol Pharm; 2018 Jan; 15(1):1-11. PubMed ID: 29182876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Buffers in Protein Formulations.
    Zbacnik TJ; Holcomb RE; Katayama DS; Murphy BM; Payne RW; Coccaro RC; Evans GJ; Matsuura JE; Henry CS; Manning MC
    J Pharm Sci; 2017 Mar; 106(3):713-733. PubMed ID: 27894967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
    Stärtzel P; Gieseler H; Gieseler M; Abdul-Fattah AM; Adler M; Mahler HC; Goldbach P
    J Pharm Sci; 2015 Jul; 104(7):2345-58. PubMed ID: 25994980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress Tolerance of Antibody-Poly(Amino Acid) Complexes for Improving the Stability of High Concentration Antibody Formulations.
    Izaki S; Kurinomaru T; Handa K; Kimoto T; Shiraki K
    J Pharm Sci; 2015 Aug; 104(8):2457-63. PubMed ID: 26036204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid spray formulations of xibornol by using self-microemulsifying drug delivery systems.
    Cirri M; Mura P; Mora PC
    Int J Pharm; 2007 Aug; 340(1-2):84-91. PubMed ID: 17531411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies.
    Wang S; Zhang N; Hu T; Dai W; Feng X; Zhang X; Qian F
    Mol Pharm; 2015 Dec; 12(12):4478-87. PubMed ID: 26528726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical degradation of proteins in the solid state with a focus on photochemical reactions.
    Mozziconacci O; Schöneich C
    Adv Drug Deliv Rev; 2015 Oct; 93():2-13. PubMed ID: 25481682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a lyophilised RH1 formulation: a novel DT diaphorase activated alkylating agent.
    Elliott MA; Ford SJ; Walker AA; Hargreaves RH; Halbert GW
    J Pharm Pharmacol; 2002 Apr; 54(4):487-92. PubMed ID: 11999125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid-state protein formulations.
    Angkawinitwong U; Sharma G; Khaw PT; Brocchini S; Williams GR
    Ther Deliv; 2015 Jan; 6(1):59-82. PubMed ID: 25565441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.